Bryan King - Publications

Affiliations: 
2008 University of California, San Francisco, San Francisco, CA 

14/131 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Siegel M, McGuire K, Veenstra-VanderWeele J, Stratigos K, King B, Bellonci C, Hayek M, Keable H, Rockhill C, Bukstein OG, Walter HJ. Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder) Journal of the American Academy of Child and Adolescent Psychiatry. 59: 468-496. DOI: 10.1016/J.Jaac.2019.11.018  0.355
2018 Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Comprehensive Psychiatry. 88: 57-64. PMID 30504071 DOI: 10.1016/J.Comppsych.2018.10.012  0.357
2018 Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29540864 DOI: 10.1038/S41386-018-0039-3  0.339
2015 Kasari C, Dean M, Kretzmann M, Shih W, Orlich F, Whitney R, Landa R, Lord C, King B. Children with autism spectrum disorder and social skills groups at school: a randomized trial comparing intervention approach and peer composition. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 26391889 DOI: 10.1111/Jcpp.12460  0.333
2015 Carr T, Shih W, Lawton K, Lord C, King B, Kasari C. The relationship between treatment attendance, adherence, and outcome in a caregiver-mediated intervention for low-resourced families of young children with autism spectrum disorder. Autism : the International Journal of Research and Practice. PMID 26290524 DOI: 10.1177/1362361315598634  0.311
2015 Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L. Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder. Autism : the International Journal of Research and Practice. PMID 26187059 DOI: 10.1177/1362361315593941  0.377
2014 Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 237-57. PMID 24472258 DOI: 10.1016/J.Jaac.2013.10.013  0.369
2014 Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 97-107.e1. PMID 24342389 DOI: 10.1016/J.Jaac.2013.09.018  0.346
2013 Sterling L, Munson J, Estes A, Murias M, Webb SJ, King B, Dawson G. Fear-potentiated startle response is unrelated to social or emotional functioning in adolescents with autism spectrum disorders. Autism Research : Official Journal of the International Society For Autism Research. 6: 320-31. PMID 23495221 DOI: 10.1002/Aur.1289  0.33
2012 Scahill L, McCracken JT, Bearss K, Robinson F, Hollander E, King B, Bregman J, Sikich L, Dukes K, Sullivan L, Anagnostou E, Donnelly C, Kim YS, Ritz L, Hirtz D, et al. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 42: 432-40. PMID 21667200 DOI: 10.1007/S10803-011-1251-8  0.323
2011 Nord AS, Roeb W, Dickel DE, Walsh T, Kusenda M, O'Connor KL, Malhotra D, McCarthy SE, Stray SM, Taylor SM, Sebat J, King B, King MC, McClellan JM. Reduced transcript expression of genes affected by inherited and de novo CNVs in autism. European Journal of Human Genetics : Ejhg. 19: 727-31. PMID 21448237 DOI: 10.1038/Ejhg.2011.24  0.316
2009 Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegué E. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell. 15: 341-52. PMID 19345332 DOI: 10.1016/J.Ccr.2009.02.016  0.553
2008 Santaguida MT, Schepers K, King BC, Passegue E. JunB Limits Hematopoietic Stem Cell (HSC) Functions as a Protective Mechanism against Initiation of Myeloid Malignancy Blood. 112: 1358-1358. DOI: 10.1182/Blood.V112.11.1358.1358  0.559
2007 Santaguida M, Schepers K, King B, Passegue E. Deciphering JunB Function in Regulating Hematopoietic Stem Cell Functions. Blood. 110: 777-777. DOI: 10.1182/Blood.V110.11.777.777  0.557
Low-probability matches (unlikely to be authored by this person)
2014 Kasari C, Lawton K, Shih W, Barker TV, Landa R, Lord C, Orlich F, King B, Wetherby A, Senturk D. Caregiver-mediated intervention for low-resourced preschoolers with autism: an RCT. Pediatrics. 134: e72-9. PMID 24958585 DOI: 10.1542/Peds.2013-3229  0.3
2018 Finley LWS, Vardhana SA, Carey BW, Alonso-Curbelo D, Koche R, Chen Y, Wen D, King B, Radler MR, Rafii S, Lowe SW, Allis CD, Thompson CB. Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity. Nature Cell Biology. PMID 29662175 DOI: 10.1038/S41556-018-0086-3  0.296
2016 King B, Boccalatte F, Moran-Crusio K, Wolf E, Wang J, Kayembe C, Lazaris C, Yu X, Aranda-Orgilles B, Lasorella A, Aifantis I. The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells. Nature Immunology. PMID 27668798 DOI: 10.1038/Ni.3559  0.287
2021 Sikich L, Kolevzon A, King BH, McDougle CJ, Sanders KB, Kim SJ, Spanos M, Chandrasekhar T, Trelles MDP, Rockhill CM, Palumbo ML, Witters Cundiff A, Montgomery A, Siper P, Minjarez M, et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. The New England Journal of Medicine. 385: 1462-1473. PMID 34644471 DOI: 10.1056/NEJMoa2103583  0.275
2014 Dean M, Kasari C, Shih W, Frankel F, Whitney R, Landa R, Lord C, Orlich F, King B, Harwood R. The peer relationships of girls with ASD at school: comparison to boys and girls with and without ASD. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 55: 1218-25. PMID 25039696 DOI: 10.1111/Jcpp.12242  0.271
2023 Hirota T, King BH. Autism Spectrum Disorder: A Review. Jama. 329: 157-168. PMID 36625807 DOI: 10.1001/jama.2022.23661  0.262
2020 Siegel M, McGuire K, Veenstra-VanderWeele J, Stratigos K, King B, Bellonci C, Hayek M, Keable H, Rockhill C, Bukstein OG, Walter HJ. Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder). Journal of the American Academy of Child and Adolescent Psychiatry. 59: 468-496. PMID 33928910 DOI: 10.1016/j.jaac.2019.11.018  0.257
2014 Erickson CA, Veenstra-Vanderweele JM, Melmed RD, McCracken JT, Ginsberg LD, Sikich L, Scahill L, Cherubini M, Zarevics P, Walton-Bowen K, Carpenter RL, Bear MF, Wang PP, King BH. STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. Journal of Autism and Developmental Disorders. 44: 958-64. PMID 24272415 DOI: 10.1007/S10803-013-1963-Z  0.254
2018 Rynkiewicz A, King B, Kalisz K, Słopień A, Janas-Kozik M, Łucka I, Poland ESAG, Children. Competent users and standards of use for Autism Diagnostic Interview – Revised (ADI-R) and Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Psychiatria I Psychologia Kliniczna. 18: 399-404. DOI: 10.15557/Pipk.2018.0047  0.252
2014 Hilt R, Wolf C, Koprowicz K, Thomas E, Chandler M, Hao XL, Russell M, Le T, Hooks L, King B. Community child psychiatric medication experiences measured by an internet-based, prospective parent survey of retail pharmacy customers. Community Mental Health Journal. 50: 172-8. PMID 24323138 DOI: 10.1007/S10597-013-9671-X  0.251
2022 Simonoff E, Mowlem F, Pearson O, Anagnostou E, Donnelly C, Hollander E, King BH, McCracken JT, Scahill L, Sikich L, Pickles A. Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology. 32: 233-241. PMID 35501967 DOI: 10.1089/cap.2021.0137  0.247
2017 Howes OD, Rogdaki M, Findon JL, Wichers RH, Charman T, King BH, Loth E, McAlonan GM, McCracken JT, Parr JR, Povey C, Santosh P, Wallace S, Simonoff E, Murphy DG. Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. Journal of Psychopharmacology (Oxford, England). 269881117741766. PMID 29237331 DOI: 10.1177/0269881117741766  0.245
2005 Bostic JQ, King BH. Autism spectrum disorders: emerging pharmacotherapy. Expert Opinion On Emerging Drugs. 10: 521-36. PMID 16083327 DOI: 10.1517/14728214.10.3.521  0.244
2019 King BH. Fluoxetine and Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorder. Jama. 322: 1557-1558. PMID 31638657 DOI: 10.1001/jama.2019.11738  0.238
2009 King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry. 66: 583-90. PMID 19487623 DOI: 10.1001/Archgenpsychiatry.2009.30  0.237
2016 Veenstra-VanderWeele J, Cook EH, King BH, Zarevics P, Cherubini M, Walton-Bowen K, Bear MF, Wang PP, Carpenter RL. Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27748740 DOI: 10.1038/Npp.2016.237  0.236
2015 Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, et al. Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. 19: 38-52. PMID 24259748 DOI: 10.1177/1362361313510069  0.232
2015 Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, Sanders R, Minjarez M, Cowen J, Mullett J, Page C, Ward D, Deng Y, Loo S, Dziura J, et al. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. The American Journal of Psychiatry. appiajp201515010055. PMID 26315981 DOI: 10.1176/Appi.Ajp.2015.15010055  0.232
2019 Ness SL, Bangerter A, Manyakov NV, Lewin D, Boice M, Skalkin A, Jagannatha S, Chatterjee M, Dawson G, Goodwin MS, Hendren R, Leventhal B, Shic F, Frazier JA, Janvier Y, ... King BH, et al. An Observational Study With the Janssen Autism Knowledge Engine (JAKE) in Individuals With Autism Spectrum Disorder. Frontiers in Neuroscience. 13: 111. PMID 30872988 DOI: 10.3389/Fnins.2019.00111  0.23
2014 King BH, de Lacy N, Siegel M. Psychiatric assessment of severe presentations in autism spectrum disorders and intellectual disability. Child and Adolescent Psychiatric Clinics of North America. 23: 1-14. PMID 24231163 DOI: 10.1016/j.chc.2013.07.001  0.226
2014 King BH, Navot N, Bernier R, Webb SJ. Update on diagnostic classification in autism. Current Opinion in Psychiatry. 27: 105-9. PMID 24441420 DOI: 10.1097/Yco.0000000000000040  0.226
2015 King BH. Promising forecast for autism spectrum disorders. Jama. 313: 1518-9. PMID 25898047 DOI: 10.1001/jama.2015.2628  0.224
2016 Yu C, King BH. Focus on Autism and Related Conditions. Focus (American Psychiatric Publishing). 14: 3-8. PMID 31975786 DOI: 10.1176/appi.focus.20150030  0.222
1997 Dykens EM, Goff BJ, Hodapp RM, Davis L, Devanzo P, Moss F, Halliday J, Shah B, State M, King B. Eating themselves to death: have "personal rights" gone too far in treating people with Prader-Willi syndrome? Mental Retardation. 35: 312-4. PMID 9270240 DOI: 10.1352/0047-6765(1997)035<0312:Ettdhp>2.0.Co;2  0.22
2020 King B, Araki J, Palm W, Thompson CB. Yap/Taz promote the scavenging of extracellular nutrients through macropinocytosis. Genes & Development. PMID 32912902 DOI: 10.1101/Gad.340661.120  0.22
2014 Marrus N, Veenstra-Vanderweele J, Hellings JA, Stigler KA, Szymanski L, King BH, Carlisle LL, Cook EH, Pruett JR. Training of child and adolescent psychiatry fellows in autism and intellectual disability. Autism : the International Journal of Research and Practice. 18: 471-5. PMID 24113341 DOI: 10.1177/1362361313477247  0.218
2013 Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/S10803-013-1775-1  0.216
2013 King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial. Jama Pediatrics. 167: 1045-52. PMID 24061784 DOI: 10.1001/Jamapediatrics.2013.2698  0.215
2023 Siecinski SK, Giamberardino SN, Spanos M, Hauser AC, Gibson JR, Chandrasekhar T, Trelles MDP, Rockhill CM, Palumbo ML, Cundiff AW, Montgomery A, Siper P, Minjarez M, Nowinski LA, Marler S, ... ... King BH, et al. Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder. Autism Research : Official Journal of the International Society For Autism Research. PMID 36609850 DOI: 10.1002/aur.2884  0.215
2006 King BH, Bostic JQ. An update on pharmacologic treatments for autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 15: 161-75. PMID 16321729 DOI: 10.1016/j.chc.2005.08.005  0.211
2011 King BH, Lord C. Is schizophrenia on the autism spectrum? Brain Research. 1380: 34-41. PMID 21078305 DOI: 10.1016/J.Brainres.2010.11.031  0.21
2016 Jane Webb S, Garrison MM, Bernier R, McClintic AM, King BH, Mourad PD. Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound. Autism Research : Official Journal of the International Society For Autism Research. PMID 27582229 DOI: 10.1002/Aur.1690  0.21
2015 Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, et al. TET1 is a tumor suppressor of hematopoietic malignancy. Nature Immunology. 16: 653-62. PMID 25867473 DOI: 10.1038/Ni.3148  0.208
2014 Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, et al. Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1128-43. PMID 24158679 DOI: 10.1007/S10803-013-1974-9  0.208
2016 King BH. Psychiatric comorbidities in neurodevelopmental disorders. Current Opinion in Neurology. PMID 26840045 DOI: 10.1097/WCO.0000000000000299  0.205
2012 Swedo SE, Baird G, Cook EH, Happé FG, Harris JC, Kaufmann WE, King BH, Lord CE, Piven J, Rogers SJ, Spence SJ, Wetherby A, Wright HH. Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 347-9. PMID 22449639 DOI: 10.1016/J.Jaac.2012.02.013  0.197
2014 Siegel M, King BH. Autism and developmental disorders: management of serious behavioral disturbance. Child and Adolescent Psychiatric Clinics of North America. 23: xiii-xv. PMID 24231174 DOI: 10.1016/j.chc.2013.08.007  0.197
2008 Brkanac Z, Raskind WH, King BH. Pharmacology and genetics of autism: implications for diagnosis and treatment. Personalized Medicine. 5: 599-607. PMID 19727434 DOI: 10.2217/17410541.5.6.599  0.196
2014 King BH. Sunsetting DSM-IV's pervasive developmental disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 494-6. PMID 24745948 DOI: 10.1016/j.jaac.2014.01.013  0.191
2003 Foster B, King BH. Asperger syndrome: to be or not to be? Current Opinion in Pediatrics. 15: 491-4. PMID 14508298 DOI: 10.1097/00008480-200310000-00008  0.186
2015 King BH. Assessing Risk of Autism Spectrum Disorder in Children After Antidepressant Use During Pregnancy. Jama Pediatrics. 1-2. PMID 26660503 DOI: 10.1001/jamapediatrics.2015.3493  0.186
2019 Jiang J, Srivastava S, Seim G, Pavlova NN, King B, Zou L, Zhang C, Zhong M, Feng H, Kapur R, Wek RC, Fan J, Zhang J. Promoter demethylation of the asparagine synthetase gene is required for an ATF4-dependent adaptation to asparagine depletion. The Journal of Biological Chemistry. PMID 31659118 DOI: 10.1074/Jbc.Ra119.010447  0.185
2013 King B, Trimarchi T, Reavie L, Xu L, Mullenders J, Ntziachristos P, Aranda-Orgilles B, Perez-Garcia A, Shi J, Vakoc C, Sandy P, Shen SS, Ferrando A, Aifantis I. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell. 153: 1552-66. PMID 23791182 DOI: 10.1016/J.Cell.2013.05.041  0.182
2008 Toth K, King BH. Asperger's syndrome: diagnosis and treatment. The American Journal of Psychiatry. 165: 958-63. PMID 18676600 DOI: 10.1176/Appi.Ajp.2008.08020272  0.178
2019 Cantor DJ, King B, Blumenberg L, DiMauro T, Aifantis I, Koralov SB, Skok JA, David G. Impaired Expression of Rearranged Immunoglobulin Genes and Premature p53 Activation Block B Cell Development in BMI1 Null Mice. Cell Reports. 26: 108-118.e4. PMID 30605667 DOI: 10.1016/J.Celrep.2018.12.030  0.176
2004 Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. Outcome measures for clinical drug trials in autism. Cns Spectrums. 9: 36-47. PMID 14999174 DOI: 10.1017/S1092852900008348  0.174
2020 Vardhana SA, Hwee MA, Berisa M, Wells DK, Yost KE, King B, Smith M, Herrera PS, Chang HY, Satpathy AT, van den Brink MRM, Cross JR, Thompson CB. Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen. Nature Immunology. PMID 32661364 DOI: 10.1038/S41590-020-0725-2  0.171
2022 Carpenter KLH, Davis NO, Spanos M, Sabatos-DeVito M, Aiello R, Baranek GT, Compton SN, Egger HL, Franz L, Kim SJ, King BH, Kolevzon A, McDougle CJ, Sanders K, Veenstra-VanderWeele J, et al. Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms. Journal of Autism and Developmental Disorders. PMID 36222990 DOI: 10.1007/s10803-022-05753-2  0.17
2013 de Lacy N, King BH. Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology. Annual Review of Clinical Psychology. 9: 555-87. PMID 23537488 DOI: 10.1146/annurev-clinpsy-050212-185627  0.168
2012 Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, Estes AM, Goldowitz D, Heck DH, Kemper TL, King BH, et al. Consensus paper: pathological role of the cerebellum in autism. Cerebellum (London, England). 11: 777-807. PMID 22370873 DOI: 10.1007/S12311-012-0355-9  0.167
2015 de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatric Neurology. 52: 25-35. PMID 25532776 DOI: 10.1016/J.Pediatrneurol.2014.10.004  0.162
2014 Ntziachristos P, Tsirigos A, Welstead GG, Trimarchi T, Bakogianni S, Xu L, Loizou E, Holmfeldt L, Strikoudis A, King B, Mullenders J, Becksfort J, Nedjic J, Paietta E, Tallman MS, et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature. 514: 513-7. PMID 25132549 DOI: 10.1038/Nature13605  0.16
2019 Morioka H, Ijichi S, Ijichi N, Ijichi Y, King BH. Developmental social vulnerability as the intrinsic origin of psychopathology: A paradigm shift from disease entities to psychiatric derivatives within human diversity. Medical Hypotheses. 126: 95-108. PMID 31010507 DOI: 10.1016/j.mehy.2019.03.015  0.155
2020 Bradshaw J, Gillespie S, McCracken C, King BH, McCracken JT, Johnson CR, Lecavalier L, Smith T, Swiezy N, Bearss K, Sikich L, Donnelly C, Hollander E, McDougle CJ, Scahill L. Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 33151499 DOI: 10.1007/s10803-020-04625-x  0.155
2014 McClintic AM, King BH, Webb SJ, Mourad PD. Mice exposed to diagnostic ultrasound in utero are less social and more active in social situations relative to controls. Autism Research : Official Journal of the International Society For Autism Research. 7: 295-304. PMID 24249575 DOI: 10.1002/Aur.1349  0.147
2012 King B, Ntziachristos P, Aifantis I. Hijacking T cell differentiation: new insights in TLX function in T-ALL. Cancer Cell. 21: 453-5. PMID 22516255 DOI: 10.1016/J.Ccr.2012.03.026  0.145
2013 King BH, Veenstra-Vanderweele J, Lord C. DSM-5 and autism: kicking the tires and making the grade. Journal of the American Academy of Child and Adolescent Psychiatry. 52: 454-7. PMID 23622845 DOI: 10.1016/J.Jaac.2013.02.009  0.144
2004 Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R. Impact of recent findings on study design of future autism clinical trials. Cns Spectrums. 9: 49-56. PMID 14999175 DOI: 10.1017/S109285290000835X  0.142
2022 Rynkiewicz A, Dembiński Ł, Koletzko B, Michaud PA, Hadjipanayis A, Grossman Z, Korslund K, King BH, Treasure J, Peregud-Pogorzelski J, Del Torso S, Valiulis A, Mazur A. Adolescents With Eating Disorders in Pediatric Practice - The European Academy of Paediatrics Recommendations. Frontiers in Pediatrics. 10: 806399. PMID 35558369 DOI: 10.3389/fped.2022.806399  0.14
2014 Hilt RJ, Chaudhari M, Bell JF, Wolf C, Koprowicz K, King BH. Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents. Journal of Child and Adolescent Psychopharmacology. 24: 83-9. PMID 24506790 DOI: 10.1089/cap.2013.0036  0.134
2017 King BH. Association Between Maternal Use of SSRI Medications and Autism in Their Children. Jama. 317: 1568-1569. PMID 28418468 DOI: 10.1001/jama.2016.20614  0.132
2020 Spanos M, Chandrasekhar T, Kim SJ, Hamer RM, King BH, McDougle CJ, Sanders KB, Gregory SG, Kolevzon A, Veenstra-VanderWeele J, Sikich L. Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B). Contemporary Clinical Trials. 106103. PMID 32777383 DOI: 10.1016/J.Cct.2020.106103  0.132
2015 Pitt LA, Tikhonova AN, Hu H, Trimarchi T, King B, Gong Y, Sanchez-Martin M, Tsirigos A, Littman DR, Ferrando AA, Morrison SJ, Fooksman DR, Aifantis I, Schwab SR. CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance. Cancer Cell. 27: 755-68. PMID 26058075 DOI: 10.1016/J.Ccell.2015.05.002  0.125
2023 Gargano MA, Matentzoglu N, Coleman B, Addo-Lartey EB, Anagnostopoulos AV, Anderton J, Avillach P, Bagley AM, Bakštein E, Balhoff JP, Baynam G, Bello SM, Berk M, Bertram H, Bishop S, ... ... King B, et al. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Research. PMID 37953324 DOI: 10.1093/nar/gkad1005  0.118
2015 Ye J, Palm W, Peng M, King B, Lindsten T, Li MO, Koumenis C, Thompson CB. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes & Development. PMID 26543160 DOI: 10.1101/Gad.269324.115  0.117
2021 Pappalardi MB, Keenan K, Cockerill M, Kellner WA, Stowell A, Sherk C, Wong K, Pathuri S, Briand J, Steidel M, Chapman P, Groy A, Wiseman AK, McHugh CF, Campobasso N, ... ... King BW, et al. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nature Cancer. 2: 1002-1017. PMID 34790902  0.113
2006 Bejerano G, Lowe CB, Ahituv N, King B, Siepel A, Salama SR, Rubin EM, Kent WJ, Haussler D. A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature. 441: 87-90. PMID 16625209 DOI: 10.1038/Nature04696  0.109
2014 Li N, Fassl A, Chick J, Inuzuka H, Li X, Mansour MR, Liu L, Wang H, King B, Shaik S, Gutierrez A, Ordureau A, Otto T, Kreslavsky T, Baitsch L, et al. Cyclin C is a haploinsufficient tumour suppressor. Nature Cell Biology. 16: 1080-91. PMID 25344755 DOI: 10.1038/Ncb3046  0.104
2016 Bonilla X, Parmentier L, King B, Bezrukov F, Kaya G, Zoete V, Seplyarskiy VB, Sharpe HJ, McKee T, Letourneau A, Ribaux PG, Popadin K, Basset-Seguin N, Chaabene RB, Santoni FA, et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nature Genetics. 48: 398-406. PMID 26950094 DOI: 10.1038/Ng.3525  0.102
2010 Yen CF, King BH, Chang YP. Factor structure of the Athens Insomnia Scale and its associations with demographic characteristics and depression in adolescents. Journal of Sleep Research. 19: 12-8. PMID 19682243 DOI: 10.1111/j.1365-2869.2009.00758.x  0.101
2016 Stein MA, King BH. Unequal Individual Risk and Potential Benefit Balanced by Benefits to the Population at Large in Autism Clinical Trials? The American Journal of Bioethics : Ajob. 16: 72-74. PMID 26982936 DOI: 10.1080/15265161.2016.1145298  0.1
2017 Palm W, Araki J, King B, DeMatteo RG, Thompson CB. Critical role for PI3-kinase in regulating the use of proteins as an amino acid source. Proceedings of the National Academy of Sciences of the United States of America. PMID 28973876 DOI: 10.1073/Pnas.1712726114  0.099
2020 Li X, Pritykin Y, Concepcion CP, Lu Y, La Rocca G, Zhang M, King B, Cook PJ, Au YW, Popow O, Paulo JA, Otis HG, Mastroleo C, Ogrodowski P, Schreiner R, et al. High-Resolution In Vivo Identification of miRNA Targets by Halo-Enhanced Ago2 Pull-Down. Molecular Cell. PMID 32497496 DOI: 10.1016/J.Molcel.2020.05.009  0.096
2021 Schwörer S, Pavlova NN, Cimino FV, King B, Cai X, Sizemore GM, Thompson CB. Fibroblast pyruvate carboxylase is required for collagen production in the tumour microenvironment. Nature Metabolism. 3: 1484-1499. PMID 34764457 DOI: 10.1038/s42255-021-00480-x  0.091
2005 Hunt DL, King B, Kahn DM, Yamoah EN, Shull GE, Krubitzer L. Aberrant retinal projections in congenitally deaf mice: how are phenotypic characteristics specified in development and evolution? The Anatomical Record. Part a, Discoveries in Molecular, Cellular, and Evolutionary Biology. 287: 1051-66. PMID 16200647 DOI: 10.1002/Ar.A.20251  0.09
2020 Pavlova NN, King B, Josselsohn RH, Violante S, Macera VL, Vardhana SA, Cross JR, Thompson CB. Translation in amino acid-poor environments is limited by tRNA charging. Elife. 9. PMID 33289483 DOI: 10.7554/eLife.62307  0.09
2019 Haile PA, Casillas LN, Votta BJ, Wang GZ, Charnley AK, Dong X, Bury MJ, Romano JJ, Mehlmann JF, King BW, Erhard KF, Hanning CR, Lipshutz DB, Desai BM, Capriotti CA, et al. Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[ d]thiazol-5-ylamino)-6-( tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. PMID 31265286 DOI: 10.1021/acs.jmedchem.9b00575  0.089
2017 Harris PA, Berger SB, Jeong JU, Nagilla R, Bandyopadhyay D, Campobasso N, Capriotti CA, Cox JA, Dare L, Dong X, Eidam PM, Finger JN, Hoffman SJ, Kang J, Kasparcova V, ... King BW, et al. Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. PMID 28151659 DOI: 10.1021/Acs.Jmedchem.6B01751  0.083
2006 Pollard KS, Salama SR, Lambert N, Lambot MA, Coppens S, Pedersen JS, Katzman S, King B, Onodera C, Siepel A, Kern AD, Dehay C, Igel H, Ares M, Vanderhaeghen P, et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature. 443: 167-72. PMID 16915236 DOI: 10.1038/Nature05113  0.083
2016 Haile PA, Votta BJ, Marquis RW, Bury MJ, Mehlmann JF, Singhaus RR, Charnley AK, Lakdawala AS, Convery MA, Lipshutz DB, Desai BM, Swift B, Capriotti CA, Berger SB, Mahajan MK, ... ... King BW, et al. The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK'583), a highly potent and selective inhibitor of RIP2 Kinase. Journal of Medicinal Chemistry. PMID 27109867 DOI: 10.1021/Acs.Jmedchem.6B00211  0.083
2019 Gwynette MF, McGuire K, Fadus MC, Feder JD, Koth KA, King BH. Overemphasis of the ADOS Evaluation Subverts a Clinician's Ability to Provide Access to Autism Services. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 31356862 DOI: 10.1016/j.jaac.2019.07.933  0.08
2021 King B, Ikenga A, Larsen M, Sim C. Suppressed expression of oxidoreductin-like protein, Oxidor, increases follicle degeneration and decreases survival during the overwintering diapause of the mosquito Culex pipiens. Comparative Biochemistry and Physiology. Part a, Molecular & Integrative Physiology. 110959. PMID 33862219 DOI: 10.1016/j.cbpa.2021.110959  0.078
2014 Mandal P, Berger SB, Pillay S, Moriwaki K, Huang C, Guo H, Lich JD, Finger J, Kasparcova V, Votta B, Ouellette M, King BW, Wisnoski D, Lakdawala AS, DeMartino MP, et al. RIP3 induces apoptosis independent of pronecrotic kinase activity. Molecular Cell. 56: 481-95. PMID 25459880 DOI: 10.1016/J.Molcel.2014.10.021  0.077
2014 Lévy Y, Thiébaut R, Montes M, Lacabaratz C, Sloan L, King B, Pérusat S, Harrod C, Cobb A, Roberts LK, Surenaud M, Boucherie C, Zurawski S, Delaugerre C, Richert L, et al. Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load. European Journal of Immunology. 44: 2802-10. PMID 25042008 DOI: 10.1002/Eji.201344433  0.073
2019 Harris PA, Faucher N, George N, Eidam PM, King BW, White G, Anderson NA, Bandyopadhyay D, Beal AM, Beneton V, Berger SB, Campobasso N, Campos S, Capriotti CA, Cox JA, et al. Discovery and Lead-optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase. Journal of Medicinal Chemistry. PMID 31013427 DOI: 10.1021/Acs.Jmedchem.9B00318  0.073
2013 Flamar AL, Xue Y, Zurawski SM, Montes M, King B, Sloan L, Oh S, Banchereau J, Levy Y, Zurawski G. Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells. Aids (London, England). 27: 2041-51. PMID 23615121 DOI: 10.1097/QAD.0b013e3283624305  0.071
2022 Horton JR, Pathuri S, Wong K, Ren R, Rueda L, Fosbenner DT, Heerding DA, McCabe MT, Pappalardi MB, Zhang X, King BW, Cheng X. Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors. Structure (London, England : 1993). PMID 35395178 DOI: 10.1016/j.str.2022.03.009  0.07
2019 King B, Li S, Liu C, Joon Kim S, Sim C. Suppression of glycogen synthase expression reduces glycogen and lipid storage during mosquito overwintering diapause. Journal of Insect Physiology. 103971. PMID 31705845 DOI: 10.1016/J.Jinsphys.2019.103971  0.069
2010 Yen CF, King BH, Tang TC. The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents. Psychiatry Research. 179: 69-74. PMID 20472300 DOI: 10.1016/j.psychres.2009.02.016  0.069
2021 La Rocca G, King B, Shui B, Li X, Zhang M, Akat K, Ogrodowski P, Mastroleo C, Chen K, Cavalieri V, Ma Y, Anelli V, Betel D, Vidigal J, Tuschl T, et al. Inducible and reversible inhibition of miRNA-mediated gene repression . Elife. 10. PMID 34463618 DOI: 10.7554/eLife.70948  0.069
2002 Lewis MA, Lewis CE, Leake B, King BH, Lindemann R. The quality of health care for adults with developmental disabilities. Public Health Reports (Washington, D.C. : 1974). 117: 174-84. PMID 12357002  0.068
2016 Harris PA, King BW, Bandyopadhyay D, Berger SB, Campobasso N, Capriotti CA, Cox JA, Dare L, Dong X, Finger JN, Grady LC, Hoffman SJ, Jeong JU, Kang J, Kasparcova V, et al. DNA-encoded library screening identifies benzo[b][1,4]oxazepin-4-ones as highly potent and mono-selective receptor interacting protein 1 (RIP1) kinase inhibitors. Journal of Medicinal Chemistry. PMID 26854747 DOI: 10.1021/Acs.Jmedchem.5B01898  0.068
2023 King B, Larsen M, Ikenga A, Sim C. Suppression of the gene encoding PDZ domain-containing protein decreases cold tolerance and overwintering survival of the mosquito, Culex pipiens (Culicidae: Diptera). Journal of Medical Entomology. PMID 37235642 DOI: 10.1093/jme/tjad059  0.066
2006 Pollard KS, Salama SR, King B, Kern AD, Dreszer T, Katzman S, Siepel A, Pedersen JS, Bejerano G, Baertsch R, Rosenbloom KR, Kent J, Haussler D. Forces shaping the fastest evolving regions in the human genome. Plos Genetics. 2: e168. PMID 17040131 DOI: 10.1371/Journal.Pgen.0020168  0.065
2016 Shah R, Rogers KC, Ahmed AJ, King BJ, Rao SV. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials. Jacc. Cardiovascular Interventions. PMID 27318846 DOI: 10.1016/j.jcin.2016.03.031  0.062
2000 LaHoste GJ, Wigal T, King BH, Schuck SE, Crinella FM, Swanson JM. Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states. Experimental and Clinical Psychopharmacology. 8: 125-32. PMID 10743913 DOI: 10.1037/1064-1297.8.1.125  0.062
2015 Zander AL, Olson EJ, Van Gent JM, Bandle J, Calvo RY, Shackford SR, Peck KA, Sise CB, Sise MJ, King BS. Does resuscitation with plasma increase the risk of venous thromboembolism? The Journal of Trauma and Acute Care Surgery. 78: 39-43; discussion 43. PMID 25539201 DOI: 10.1097/Ta.0000000000000480  0.061
2016 Flatt DM, Brown MC, Mizeracki AM, King BJ, Weber KT. Mineralocorticoid Receptor Antagonists in the Management of Heart Failure and Resistant Hypertension: A Review. Jama Cardiology. PMID 27434136 DOI: 10.1001/jamacardio.2016.1878  0.057
2002 Aledia AS, Tran LM, King BO, Serna DL, Eng J, Jones BU, Chen JC, Roum JH. S-nitrosoglutathione preserves platelet function during in vitro ventricular assist device circulation. Asaio Journal (American Society For Artificial Internal Organs : 1992). 48: 526-31. PMID 12296574  0.056
2006 Fagerquist CK, Bates AH, Heath S, King BC, Garbus BE, Harden LA, Miller WG. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications Journal of Proteome Research. 5: 2527-2538. PMID 17022624 DOI: 10.1021/pr050485w  0.053
2024 Barton LS, Callahan JF, Cantizani J, Concha NO, Cotillo Torrejon I, Goodwin NC, Joshi-Pangu A, Kiesow TJ, McAtee JJ, Mellinger M, Nixon CJ, Padrón-Barthe L, Patterson JR, Pearson ND, Pouliot JJ, ... ... King BW, et al. Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement. Bioorganic & Medicinal Chemistry. 100: 117618. PMID 38309201 DOI: 10.1016/j.bmc.2024.117618  0.053
2011 Cobb A, Roberts LK, Palucka AK, Mead H, Montes M, Ranganathan R, Burkeholder S, Finholt JP, Blankenship D, King B, Sloan L, Harrod AC, Lévy Y, Banchereau J. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine. Journal of Immunological Methods. 365: 27-37. PMID 21093448 DOI: 10.1016/J.Jim.2010.11.002  0.05
2015 Charnley AK, Convery MA, Lakdawala Shah A, Jones E, Hardwicke P, Bridges A, Ouellette M, Totoritis R, Schwartz B, King BW, Wisnoski DD, Kang J, Eidam PM, Votta BJ, Gough PJ, et al. Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. Bioorganic & Medicinal Chemistry. PMID 26455654 DOI: 10.1016/j.bmc.2015.09.038  0.048
2011 Totoritis R, Duraiswami C, Taylor AN, Kerrigan JJ, Campobasso N, Smith KJ, Ward P, King BW, Murrayz-Thompson M, Jones AD, Van Aller GS, Aubart KM, Zalacain M, Thrall SH, Meek TD, et al. Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors. Biochemistry. 50: 6642-54. PMID 21711014 DOI: 10.1021/Bi200655G  0.048
2017 Machutta CA, Kollmann CS, Lind KE, Bai X, Chan PF, Huang J, Ballell L, Belyanskaya S, Besra GS, Barros-Aguirre D, Bates RH, Centrella PA, Chang SS, Chai J, Choudhry AE, ... ... King BW, et al. Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nature Communications. 8: 16081. PMID 28714473 DOI: 10.1038/Ncomms16081  0.046
2014 King BR, Gladnick BP, Lee YY, Lyman S, Della Valle AG. Range of motion and function are not affected by increased post constraint in patients undergoing posterior stabilized total knee arthroplasty. The Knee. 21: 194-8. PMID 23899650 DOI: 10.1016/j.knee.2013.07.002  0.042
2015 Cimmino L, Dawlaty MM, Ndiaye-Lobry D, Yap YS, Bakogianni S, Yu Y, Bhattacharyya S, Shaknovich R, Geng H, Lobry C, Mullenders J, King B, Trimarchi T, Aranda-Orgilles B, Liu C, et al. Erratum: TET1 is a tumor suppressor of hematopoietic malignancy. Nature Immunology. 16: 889. PMID 26194287 DOI: 10.1038/Ni0815-889A  0.042
2010 Tadlock MD, Sise MJ, Riccoboni ST, Sise CB, Sack DI, Sise RG, Yang JC, Borut JJ, King BS. Damage control in the management of ruptured abdominal aortic aneurysm: preliminary results. Vascular and Endovascular Surgery. 44: 638-44. PMID 20675327 DOI: 10.1177/1538574410375132  0.04
2021 Xia B, Franklin GJ, Lu X, Bedard KL, Grady LC, Summerfield JD, Shi EX, King BW, Lind KE, Chiu C, Watts E, Bodmer V, Bai X, Marcaurelle LA. DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry. Acs Medicinal Chemistry Letters. 12: 1166-1172. PMID 34267887 DOI: 10.1021/acsmedchemlett.1c00156  0.037
2002 Hoke ME, Brescia MR, Bogaczyk S, DeShong P, King BW, Crimmins MT. Regioselectivity in the palladium-catalyzed addition of carbon nucleophiles to carbocyclic derivatives. The Journal of Organic Chemistry. 67: 327-35. PMID 11798302 DOI: 10.1021/Jo010672N  0.028
2006 Cherney RJ, King BW, Gilmore JL, Liu RQ, Covington MB, Duan JJW, Decicco CP. Conversion of potent MMP inhibitors into selective TACE inhibitors Bioorganic and Medicinal Chemistry Letters. 16: 1028-1031. PMID 16289878 DOI: 10.1016/j.bmcl.2005.10.078  0.028
2006 Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJW. Synthesis and structure-activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors Bioorganic and Medicinal Chemistry Letters. 16: 2699-2704. PMID 16516466 DOI: 10.1016/j.bmcl.2006.02.015  0.027
2020 Sloan LM, Berhe MG, Ursales A, King B, Fuchs JE. Tropism Switching Is Rare in Aviremic HIV-Infected Patients Virologically Suppressed With Non-Entry-Inhibiting Antiretroviral Regimens. The Annals of Pharmacotherapy. 1060028020927349. PMID 32462896 DOI: 10.1177/1060028020927349  0.024
2015 Bates DM, Fernandes TM, Duwe BV, King BO, Banks DA, Test VJ, Fedullo PF, Kim NH, Madani MM, Jamieson SW, Auger WR, Kerr KM. Efficacy of a Low-Tidal Volume Ventilation Strategy to Prevent Reperfusion Lung Injury after Pulmonary Thromboendarterectomy. Annals of the American Thoracic Society. PMID 26241077 DOI: 10.1513/AnnalsATS.201503-142OC  0.022
2007 Gilmore JL, King BW, Asakawa N, Harrison K, Tebben A, Sheppeck JE, Liu RQ, Covington M, Duan JJW. Synthesis and structure-activity relationship of a novel, non-hydroxamate series of TNF-α converting enzyme inhibitors Bioorganic and Medicinal Chemistry Letters. 17: 4678-4682. PMID 17576061 DOI: 10.1016/j.bmcl.2007.05.100  0.02
2018 Machutta CA, Kollmann CS, Lind KE, Bai X, Chan PF, Huang J, Ballell L, Belyanskaya S, Besra GS, Barros-Aguirre D, Bates RH, Centrella PA, Chang SS, Chai J, Choudhry AE, ... ... King BW, et al. Author Correction: Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening. Nature Communications. 9: 16227. PMID 30004092 DOI: 10.1038/Ncomms16227  0.012
1996 Crimmins MT, King BW. An Efficient Asymmetric Approach to Carbocyclic Nucleosides: Asymmetric Synthesis of 1592U89, a Potent Inhibitor of HIV Reverse Transcriptase. The Journal of Organic Chemistry. 61: 4192-4193. PMID 11667311 DOI: 10.1021/Jo960708P  0.011
Hide low-probability matches.